In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Enovis Corp (NYSE: ENOV) was $32.13 for the day, up 1.84% from the previous closing price of $31.55. In other words, the price has increased by $1.84 from its previous closing price. On the day, 0.78 million shares were traded. ENOV stock price reached its highest trading level at $32.76 during the session, while it also had its lowest trading level at $31.53.
Ratios:
Our analysis of ENOV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 2.25. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.55.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on October 03, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $62.
On June 13, 2024, JP Morgan started tracking the stock assigning a Neutral rating and target price of $53. On February 13, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $72.Stephens initiated its Overweight rating on February 13, 2024, with a $72 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 22 ’25 when Tandy Bradley J bought 3,200 shares for $31.41 per share. The transaction valued at 100,512 led to the insider holds 43,515 shares of the business.
BERRY PHILLIP BENJAMIN (BEN) bought 2,500 shares of ENOV for $74,275 on Aug 20 ’25. The SVP, Chief Financial Officer now owns 116,729 shares after completing the transaction at $29.71 per share. On Aug 13 ’25, another insider, PRYOR DANIEL A, who serves as the EVP, Strategy & Business Dev. of the company, bought 10,000 shares for $28.90 each. As a result, the insider paid 289,000 and bolstered with 161,115 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENOV now has a Market Capitalization of 1836544384 and an Enterprise Value of 3260015360. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.84 while its Price-to-Book (P/B) ratio in mrq is 0.71. Its current Enterprise Value per Revenue stands at 1.489 whereas that against EBITDA is 8.987.
Stock Price History:
The Beta on a monthly basis for ENOV is 1.48, which has changed by -0.2527907 over the last 52 weeks, in comparison to a change of 0.18469036 over the same period for the S&P500. Over the past 52 weeks, ENOV has reached a high of $49.83, while it has fallen to a 52-week low of $25.47. The 50-Day Moving Average of the stock is 7.03%, while the 200-Day Moving Average is calculated to be -13.51%.
Shares Statistics:
ENOV traded an average of 1.43M shares per day over the past three months and 993060 shares per day over the past ten days. A total of 57.16M shares are outstanding, with a floating share count of 55.92M. Insiders hold about 2.17% of the company’s shares, while institutions hold 119.44% stake in the company. Shares short for ENOV as of 1755216000 were 6644376 with a Short Ratio of 4.66, compared to 1752537600 on 7428501. Therefore, it implies a Short% of Shares Outstanding of 6644376 and a Short% of Float of 17.469999.
Earnings Estimates
The stock of Enovis Corp (ENOV) is currently in the spotlight, with 11.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $0.86, with high estimates of $0.88 and low estimates of $0.8.
Analysts are recommending an EPS of between $3.18 and $3.08 for the fiscal current year, implying an average EPS of $3.13. EPS for the following year is $3.48, with 11.0 analysts recommending between $3.77 and $3.28.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 11 analysts. It ranges from a high estimate of $546.8M to a low estimate of $533.44M. As of the current estimate, Enovis Corp’s year-ago sales were $505.22MFor the next quarter, 11 analysts are estimating revenue of $593.31M. There is a high estimate of $598.9M for the next quarter, whereas the lowest estimate is $585M.
A total of 11 analysts have provided revenue estimates for ENOV’s current fiscal year. The highest revenue estimate was $2.27B, while the lowest revenue estimate was $2.25B, resulting in an average revenue estimate of $2.26B. In the same quarter a year ago, actual revenue was $2.11BBased on 11 analysts’ estimates, the company’s revenue will be $2.4B in the next fiscal year. The high estimate is $2.43B and the low estimate is $2.38B.
